{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:24:54Z","timestamp":1790137494273,"version":"4.0.1"},"reference-count":62,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pain due to vaso-occlusive crisis is the major cause of hospital use in sickle cell disease. Although available guidelines provide recommendations for opioid administration in this setting, only 4 (21%) of 19 medical textbooks present treatment regimens that are consistent with them. Moreover, only 7 texts (37%) note that addiction is infrequent in this population, while 11 (92%) of 12 texts provide such reassurance for cancer-related pain (P &lt; .005). Finally, hydroxyurea use to decrease the frequency of vaso-occlusive crises is completely defined only in 2 textbooks. Thus, most medical texts provide neither adequate information for the treatment or prevention of pain due to vaso-occlusive crisis in sickle cell disease nor reassurance of the unlikelihood of addiction in this population. In contrast, treatment recommendations for less common hematologic disorders are consistent with current standards in 53% to 84% of appropriate texts (P &lt; .05). Limited knowledge regarding the principles and appropriateness of opioid therapy; a lack of evidence-based research on pain control; and misconceptions and prejudices about drug abuse and addiction contribute to this educational void. Thus, research and training on pain control in sickle cell disease are needed to parallel studies of environmental and genetic factors contributing to the known clinical heterogeneity of this disorder.<\/jats:p>","DOI":"10.1182\/blood-2007-07-089144","type":"journal-article","created":{"date-parts":[[2007,10,17]],"date-time":"2007-10-17T03:40:39Z","timestamp":1192592439000},"page":"997-1003","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":52,"title":["Treatment and prevention of pain due to vaso-occlusive crises in adults with sickle cell disease: an educational void"],"prefix":"10.1182","volume":"111","author":[{"given":"Lawrence R.","family":"Solomon","sequence":"first","affiliation":[{"name":"Adult Sickle Cell Disease Program, Section of Hematology, Department of Medicine, Yale University School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111723500874600_B1","article-title":"Sickle cell disease patients in US hospitals 2004.","author":"Steiner"},{"key":"2019111723500874600_B2","article-title":"Guideline for the management of acute and chronic pain in sickle-cell disease.","author":"Benjamin","year":"1999"},{"key":"2019111723500874600_B3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.1365-2141.2003.04193.x","article-title":"Guidelines for the management of the acute painful crisis in sickle cell disease.","volume":"120","author":"Rees","year":"2003","journal-title":"Brit J Haematol"},{"key":"2019111723500874600_B4","first-page":"59","article-title":"The Management of Sickle Cell Disease.","author":"National Institutes of Health","year":"2002","edition":"4th ed"},{"key":"2019111723500874600_B5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/17423953060020011101","article-title":"Pain management is sickle cell disease.","volume":"2","author":"Booker","year":"2006","journal-title":"Chronic Illn"},{"key":"2019111723500874600_B6","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia.","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"key":"2019111723500874600_B7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ajh.20353","article-title":"Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists\/oncologists.","volume":"79","author":"Zumberg","year":"2005","journal-title":"Am J Hematol"},{"key":"2019111723500874600_B8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ajh.20703","article-title":"Hospitalization rates and cost of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea.","volume":"81","author":"Lanzkron","year":"2006","journal-title":"Am J Hematol"},{"key":"2019111723500874600_B9","author":"Greer","year":"2004","edition":"11th ed."},{"key":"2019111723500874600_B10","volume-title":"Hematology: Basic Principles and Practice","author":"Hoffman","year":"2005","edition":"4th ed"},{"key":"2019111723500874600_B11","volume-title":"Williams: Hematology","author":"Lichtman","year":"2006","edition":"7th ed"},{"key":"2019111723500874600_B12","volume-title":"Blood: Principles and Practice of Hematology","author":"Handin","year":"2003","edition":"2nd ed"},{"key":"2019111723500874600_B13","volume-title":"Bethesda Handbook of Clinical Hematology","author":"Rodgers","year":"2005"},{"key":"2019111723500874600_B14","volume-title":"Hematology and Oncology Therapy","author":"Boyiadzis","year":"2007"},{"key":"2019111723500874600_B15","volume-title":"Clinical Hematology","author":"Young","year":"2006"},{"key":"2019111723500874600_B16","volume-title":"Hematology in Clinical Practice","author":"Hillman","year":"2005","edition":"4th ed"},{"key":"2019111723500874600_B17","doi-asserted-by":"crossref","DOI":"10.1002\/9780470987056","volume-title":"Postgraduate Haematology","author":"Hoffbrand","year":"2005","edition":"5th ed"},{"key":"2019111723500874600_B18","author":"Marx","year":"2006","journal-title":"Rosen's Emergency Medicine: Concepts and Clinical Practice"},{"key":"2019111723500874600_B19","author":"Tintinalli","year":"2004","journal-title":"Emergency Medicine: A Comprehensive Study Guide"},{"key":"2019111723500874600_B20","author":"Wolfson","year":"2005","journal-title":"Harwood-Nuss' Clinical Practice of Emergency Medicine"},{"key":"2019111723500874600_B21","author":"Warrell","year":"2003","journal-title":"Oxford Textbook of Medicine"},{"key":"2019111723500874600_B22","author":"Goldman","year":"2004","journal-title":"Cecil: Textbook of Medicine"},{"key":"2019111723500874600_B23","year":"2004","journal-title":"Washington Manual of Medical Therapeutics"},{"key":"2019111723500874600_B24","unstructured":"Dale\n              DD\n            \n          \n          ACP Medicine On-Line\n          Accessed October 31, 2006\n          \n            www.acpmedicine.com\/cgi.bin\/publiccgi.pl?loginOP."},{"key":"2019111723500874600_B25","author":"Kasper","year":"2005","journal-title":"Harrison's: Principles of Internal Medicine"},{"key":"2019111723500874600_B26","author":"Rakel","year":"2006","journal-title":"Conn's Current Therapy"},{"key":"2019111723500874600_B27","unstructured":"Rose\n              BD\n            \n            \n              Rush\n              JM\n            \n          \n          Up-To-Date Online, 2005\n          Accessed October 31, 2006\n          founders.\n          \n            www.uptodateonline.com\/utd\/index.do."},{"key":"2019111723500874600_B28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/J354v18n02_02","article-title":"Clinician beliefs about opioid use and barriers in chronic nonmalignant pain.","volume":"18","author":"Grahmann","year":"2004","journal-title":"J Pain Palliative Care Pharmacother"},{"key":"2019111723500874600_B29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/082585970502100403","article-title":"Physicians' attitude and practices in sickle cell disease pain management.","volume":"21","author":"Labbe","year":"2005","journal-title":"J Palliative Care"},{"key":"2019111723500874600_B30","first-page":"1328","article-title":"TJ Ryan, Chairman).","volume":"28","author":"ACC\/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology\/American Heart Association Taskforce on Practice Guidelines (Committee on Management of Acute Myocardial Infarction","year":"1996","journal-title":"J Am Col Cardiol"},{"key":"2019111723500874600_B31","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archinte.1991.00400070131017","article-title":"Intermittant injection vs patient-controlled analgesia for sickle cell pain.","volume":"151","author":"Gonzalez","year":"1991","journal-title":"Arch Intern Med"},{"key":"2019111723500874600_B32","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1213\/01.ane.0000238040.41872.7e","article-title":"A comparison of intrathecal fentanyl\/morphine and patient-controlled analgesia with patient-controlled analgesia alone after liver resection.","volume":"103","author":"Roy","year":"2006","journal-title":"Anesth Analg"},{"key":"2019111723500874600_B33","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/BF03011736","article-title":"Comparison of morphine and morphine with ketamine for postoperative analgesia.","volume":"43","author":"Jarvey","year":"1996","journal-title":"Can J Anesth"},{"key":"2019111723500874600_B34","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/00000542-199711000-00011","article-title":"Opioid-sparing effects of a low-dose infusion of naloxone in patients administered morphine sulfate.","volume":"87","author":"Gan","year":"1997","journal-title":"Anesthesiology"},{"key":"2019111723500874600_B35","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/BF03017448","article-title":"Iliohypogastric-ilioinguinal peripheral nerve block for post-Caesarian delivery analgesia decreases morphine use but not opioid-related side effects.","volume":"49","author":"Bell","year":"2002","journal-title":"Can J Anest"},{"key":"2019111723500874600_B36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1213\/00000539-198903000-00031","article-title":"Epidural morphine after anterior cruciate ligament repair: a comparison with patient-controlled intravenous morphine.","volume":"68","author":"Loper","year":"1989","journal-title":"Anesth Analg"},{"key":"2019111723500874600_B37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-3476(95)70472-8","article-title":"Intravenous morphine pharmokinetics in pediatric patients with sickle cell disease.","volume":"126","author":"Dampier","year":"1995","journal-title":"J Pediatrics"},{"key":"2019111723500874600_B38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1124\/dmd.32.1.98","article-title":"Metabolism of opioids is altered in liver microsomes of sickle cell transgenic mice.","volume":"32","author":"Nagar","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"2019111723500874600_B39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.acpain.2006.11.001","article-title":"Opioid-induced hyperalgesia: pathophysiology and clinical relevance.","volume":"9","author":"Koppert","year":"2007","journal-title":"Acute Pain"},{"key":"2019111723500874600_B40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0885-3924(91)90518-9","article-title":"Correlation of patient and caregiver ratings of cancer pain.","volume":"6","author":"Grossman","year":"1991","journal-title":"J Pain Symptom Manage"},{"key":"2019111723500874600_B41","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0735-6757(95)90163-9","article-title":"Health professional perceptions of opioid dependence among patients with pain.","volume":"13","author":"Waldrop","year":"1995","journal-title":"Am J Emerg Med"},{"key":"2019111723500874600_B42","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0885-3924(97)00019-5","article-title":"Sickle cell-related pain: perceptions of medical practitioners.","volume":"14","author":"Shapiro","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"2019111723500874600_B43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/apnr.2001.26783","article-title":"Nurses' attitudes and practices in sickle cell pain management.","volume":"14","author":"Pack-Mabien","year":"2001","journal-title":"Appl Nursing Res"},{"key":"2019111723500874600_B44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1749-6632.1989.tb24166.x","article-title":"Pain management in sickle cell disease: rationale and techniques.","volume":"565","author":"Payne","year":"1989","journal-title":"Ann NY Acad Sci"},{"key":"2019111723500874600_B45","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-116-5-364","article-title":"Treating sickle cell pain like cancer pain.","volume":"116","author":"Brookoff","year":"1992","journal-title":"Ann Intern Med"},{"key":"2019111723500874600_B46","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/014107680209500909","article-title":"Management of pain in sickle-cell disease.","volume":"95","author":"Okpala","year":"2002","journal-title":"J R Soc Med"},{"key":"2019111723500874600_B47","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archpsyc.1984.01790210031005","article-title":"Lifetime prevalence of specific psychiatric disorders in 3 sites.","volume":"41","author":"Robins","year":"1984","journal-title":"Arch Gen Psychiatry"},{"key":"2019111723500874600_B48","doi-asserted-by":"crossref","unstructured":"Wright\n              D\n            \n            \n              Sathe\n              N\n            \n            \n              Spagnola\n              K\n            \n          \n          State estimates of substance use from the 2004-2005 national surveys on drug use and health.\n          2007\n          168\n          170\n          \n            http:\/\/www.samhsa.gov","DOI":"10.1037\/e595002007-001"},{"key":"2019111723500874600_B49","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1097\/00002508-200207001-00004","article-title":"Assessment of addiction in pain-treatment settings.","volume":"18","author":"Savage","year":"2002","journal-title":"Clin J Pain"},{"key":"2019111723500874600_B50","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpainsymman.2003.12.001","article-title":"Understanding the causes of problematic pain management in sickle cell disease: evidence that pseudoaddiction plays a more important role than genuine analgesic dependence.","volume":"27","author":"Elander","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"2019111723500874600_B51","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1526-4637.2003.03034.x","article-title":"The unequal burden of pain: confronting racial and ethnic disparities in pain.","volume":"4","author":"Green","year":"2003","journal-title":"Pain Med"},{"key":"2019111723500874600_B52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ajh.1164","article-title":"Ethical issues in the management of sickle cell pain.","volume":"68","author":"Ballas","year":"2001","journal-title":"Am J Hematol"},{"key":"2019111723500874600_B53","unstructured":"Medline\/Pubmed at the United States National Library of Medicine, National Institutes of Health\n          \n            www.nlm.nih.gov\/portals\/healthcare.html."},{"key":"2019111723500874600_B54","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood.V95.4.1130.003k03a_1130_1136","article-title":"Sickle cell anemia day hospital: an approach for the management of uncomplicated pain crisis.","volume":"95","author":"Benjamin","year":"2000","journal-title":"Blood"},{"key":"2019111723500874600_B55","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1365-2141.2004.05123.x","article-title":"Day case management of sickle pain: 3 years experience in a UK sickle cell unit.","volume":"126","author":"Wright","year":"2004","journal-title":"Br J Haematol"},{"key":"2019111723500874600_B56","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jemermed.2006.07.022","article-title":"Impact of an emergency department pain management protocol on the pattern of visits of patients with sickle cell disease.","volume":"32","author":"Givens","year":"2007","journal-title":"J Emerg Med"},{"key":"2019111723500874600_B57","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.annemergmed.2005.03.010","article-title":"Intravenous morphine at 0.1 mg\/kg is not effective for controlling severe acute pain in the majority of patients.","volume":"46","author":"Bijur","year":"2005","journal-title":"Ann Emerg Med"},{"key":"2019111723500874600_B58","volume":"Vol 11","author":"Ballas","year":"1998","journal-title":"Sickle Cell Pain: Progress in Pain Research and Management"},{"key":"2019111723500874600_B59","first-page":"671","article-title":"Nature and treatment of the acute painful episodes in sickle cell disease.","volume-title":"Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management","author":"Benjamin","year":"2001"},{"key":"2019111723500874600_B60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0033-3549(04)50214-5","article-title":"Rural\/urban differences in access to and utilization of services among people in Alabama with sickle cell disease.","volume":"118","author":"Telfair","year":"2003","journal-title":"Public Health Rep"},{"key":"2019111723500874600_B61","first-page":"1","article-title":"Pain management for sickle cell disease (Review).","volume":"4","author":"Dunlop","year":"2006","journal-title":"The Cochrane Library"},{"key":"2019111723500874600_B62","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V108.11.3357.3357","article-title":"Treatment of pain due to vaso-occlusive crisis in adults with sickle cell disease: limited awareness of available guidelines.","volume":"108","author":"Solomon","year":"2006","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/3\/997\/1308202\/zh800308000997.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/3\/997\/1308202\/zh800308000997.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T04:50:26Z","timestamp":1574052626000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/111\/3\/997\/25528\/Treatment-and-prevention-of-pain-due-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,1]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,2,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2007-07-089144","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,1]]}}}